References

1. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2003;3:CD004405.

2. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351(18):1849-1859.

3. Aronin SI, Peduzzi P, Quagliarello VJ. Common-acquired bacterial meningitis: Risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998;129(11):862-869.

4. van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44-53.

5. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337(14):970-976.

6. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children—United States, 1998-2000. MMWR Recomm Rep 2002; 51(RR11):234-237.

7. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294(16):2043-2051.

8. Nigrovic LE, Kuppermann N, Malley R, et al. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med 2008;15:522-528.

9. Sejvar JJ. The evolving epidemiology of viral encephalitis. Curr Opin Neurol 2006;19:350-357.

10. Mitropoulous IF, Hermsen ED, Schafer JA, Rotschafer JC. Central nervous system infections. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 7th ed. New York City: McGraw-Hill; 2008:1743-1760.

11. Khetsuriani N, Holman RC, Anderson LJ. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis 2002;35:175-182.

12. Chamberlain MC. Neoplastic meningitis. J Clin Oncol 2005;23(15): 3605-3613.

13. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159(11):1185-1194.

14. Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002;186(Suppl 2):S225-S233.

15. Kim KS. Pathogenesis of bacterial meningitis: From bacteraemia to neuronal injury. Nat Rev Neurosci 2003;4:376-385.

16. Bashir HE, Laundy M, Booy R. Diagnosis and treatment of bacterial meningitis. Arch Dis Child 2003;88:615-620.

17. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-1284.

18. Choi C. Bacterial meningitis in aging adults. Clin Infect Dis 2001;33:1380-1385.

19. Swartz MN. Bacterial meningitis—A view of the past 90 years. N Engl J Med 2004;351(18):1826-1828.

20. van Deuren M, Brandtzaeg P, van der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13(1):144-166.

21. Lu CH, Huang CR, Chang, WN, et al. Community-acquired bacterial meningitis in adults: The epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 2002;104:352-358.

22. Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 2001;21:387-392.

23. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: An analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992;11:694-698.

24. Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990;322(3):141-147.

25. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997;336(10):708-716.

26. Pankey GA, Sabath LR. Clinical relevance of bacterio-static versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections. Clin Infect Dis 2004;38:864-870.

27. Sinner SW, Tunkel AR. Antimicrobial agents in the treatment of bacterial meningitis. Infect Dis Clin N Am 2004;18:581-602.

28. Tice AD, Strait K, Ramey R, et al. Outpatient parenteral antimicrobial therapy for central nervous system infections. Clin Infect Dis 1999;29:1394-1399.

29. Jones ME, Draghi DC, Karlowsky JA, Sahm DF, Bradley JS. Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002 (Online. Updated March 25, 2004). Ann Clin Microb 2004;3:3 (online journal published March 25, 2004).

30. Centers for Disease Control and Prevention. Prevention and control of meningo-coccal disease. MMWR Recomm Rep 2005;54(RR07): 1-21.

31. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344(18):1378-1388.

32. Campos-Outcalt D. Meningococcal vaccine: New product, new recommendations. J Fam Pract 2005;54(4):324-326.

33. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998-2003. Morb Mortal Wkly Rep 2005;54(36):893-897.

34. Mylonakis D, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes: 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine 1998;77(5):313-336.

35. Hof H. An update on the medical management of Listeriosis. Expert Opin Phar-macother 2004;5(8):1727-1735.

36. Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease. MMWR Recomm Rep 2002;51(RR11): 1-22.

37. Shah S, Ohlsson A, Shah V. Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev 2004;4:CD004496.

38. Villani P, Regazzi MB, Marubbi F, et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002;46(3):936-937.

39. Anderson EJ, Yogev R. A rational approach to the management of ventricular shunt infections. Pediatr Infect Dis J 2005;24:557-558.

40. Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008;47:588-589.

41. Sawyer MH. Enterovirus infections: Diagnosis and treatment. Pediatr Infect Dis J 1999;18(12):1033-1040.

42. Barker FG. Efficacy of prophylactic antibiotics against meningitis after craniotomy: A meta-analysis. Neurosurgery 2007;60:887-894.

43. Korinek AM, Golmard JL, Elcheick A, et al. Risk factors for neurosurgical site infections after craniotomy: A critical reappraisal of antibiotic prophylaxis on 4,578 patients. Br J Neurosurg 2005;19: 155-162.

44. Reichert MC, Medeiros EA, Ferraz FA. Hospital-acquired meningitis in patients undergoing craniotomy: Incidence, evolution, and risk factors. Am J Infect Control 2002;30:158-164.

45. Tyler KL. Herpes simplex virus infections of the central nervous system: Encephalitis and meningitis, including Mollaret's. Herpes 2004;11(Suppl 2):57A-64A.

46. Kimberlin D. Herpes simplex virus, meningitis and encephalitis in neonates. Herpes 2004;11(Suppl 2):65A-76A.

47. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47:303-327.

48. Roos KL. Encephalitis. Neurol Clin 1999;17:813-833.

49. American Academy of Pediatrics. Pneumococcal infections. In: Pickering, LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:490-500.

50. Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA2008;299(17):2048-2055.

51. de Gans J, van de Beek D, for the European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. N Engl J Med 2002;347(20):1549-1556.

52. Scarborough M, Gordon SB, Whitty CJM, et al. Corticosteroids for bacterial meningitis in adults in Sub-Saharan Africa. N Engl J Med 2007;357:2441-2450.

53. Ricard JD, Wolff M, Lacherade JC, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: A prospective multicenter observational study. Clin Infect Dis 2007;44:250-255.

71 Lower Respiratory Tract Infections

Diane M. Cappelletty

LEARNING OBJECTIVES

The Prevention and Treatment of Headaches

The Prevention and Treatment of Headaches

Are Constant Headaches Making Your Life Stressful? Discover Proven Methods For Eliminating Even The Most Powerful Of Headaches, It’s Easier Than You Think… Stop Chronic Migraine Pain and Tension Headaches From Destroying Your Life… Proven steps anyone can take to overcome even the worst chronic head pain…

Get My Free Audio Book


Post a comment